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A B S T R A C T   
Liver is a unique organ in displaying a reparative and regenerative response after acute/chronic damage or 
partial hepatectomy, when all the cell types must proliferate to re-establish the liver mass. The NADPH oxidase 
NOX4 mediates Transforming Growth Factor-beta (TGF-β) actions, including apoptosis in hepatocytes and 
activation of stellate cells to myofibroblasts. Aim of this work was to analyze the impact of NOX4 in liver 
regeneration by using two mouse models where Nox4 was deleted: 1) general deletion of Nox4 (NOX4− /− ) and 
2) hepatocyte-specific deletion of Nox4 (NOX4hepKO). Liver regeneration was analyzed after 2/3 partial hep-
atectomy (PH). Results indicated an earlier recovery of the liver-to-body weight ratio in both NOX4− /− and 
NOX4hepKO mice and an increased survival, when compared to corresponding WT mice. The regenerative he-
patocellular fat accumulation and the parenchyma organization recovered faster in NOX4 deleted livers. He-
patocyte proliferation, analyzed by Ki67 and phospho-Histone3 immunohistochemistry, was accelerated and 
increased in NOX4 deleted mice, coincident with an earlier and increased Myc expression. Primary hepatocytes 
isolated from NOX4 deleted mice showed higher proliferative capacity and increased expression of Myc and 
different cyclins in response to serum. Transcriptomic analysis through RNA-seq revealed significant changes 
after PH in NOX4− /− mice and support a relevant role for Myc in a node of regulation of proliferation-related 
genes. Interestingly, RNA-seq also revealed changes in the expression of genes related to activation of the TGF-β 
pathway. In fact, levels of active TGF-β1, phosphorylation of Smads and levels of its target p21 were lower at 24 h 
in NOX4 deleted mice. Nox4 did not appear to be essential for the termination of liver regeneration in vivo, 
neither for the in vitro hepatocyte response to TGF-β1 in terms of growth inhibition, which suggest its potential as 
therapeutic target to improve liver regeneration, without adverse effects.   
1. Introduction 
The NADPH oxidase (NOX) family has recently emerged as an 
important source of reactive oxygen species (ROS), which play relevant 
roles in signal transduction under both physiological and pathological 
situations [1]. The NOX4 isoform shows unique characteristics 
compared to other NOXes [2], since it produces large amounts of 
hydrogen peroxide (H2O2) constitutively, does not require GTPase Rac 
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for its activity and it is associated not only to cell membrane, but also to 
internal membranes, where H2O2 generation occurs [3]. In the liver, 
NOX4 plays relevant roles mediating Transforming Growth Factor-beta 
(TGF-β) actions in fibrosis and hepatocarcinogenesis [4,5]. We previ-
ously described that NOX4 mediates TGF-β1-induced myofibroblast 
activation, contributing to the development of liver fibrosis [6,7]. 
Indeed, there is an increasing interest in the development of NOX4 in-
hibitors as therapeutic tools for chronic liver diseases [8]. However, in 
hepatocytes and liver tumor cells, we found that NOX4 mediates 
TGF-β1-induced tumor suppressor actions, particularly apoptosis [9]. 
Furthermore, when NOX4 expression is knocked-down in hepatocellular 
carcinoma (HCC) cells, they acquire higher proliferative and migratory 
capacity in vitro and higher tumorigenic potential in in vivo xenografts in 
nude mice [10,11]. Interestingly, NOX4 gene deletions were found in 
HCC patients, which correlate with a decrease in NOX4 protein levels 
[11]. 
Liver regeneration is the response to loss of hepatic tissue, which may 
occur as a result of toxic injury, exposure to infection, traumatic damage 
or surgical resection [12]. Hepatocytes are the major functional cells of 
the liver. Indeed, in most cases, the regenerative response is strongly 
triggered when there is a loss of hepatocytes at a large scale. Many genes 
are involved in liver regeneration, but the essential circuitry for the 
process involves the participation of cytokines, growth factors and 
metabolic networks [13]. Under normal conditions, all hepatic cells 
undergo one to three rounds of replication, but evidence strongly sug-
gests that under conditions where the proliferation of hepatocytes or 
biliary cells is inhibited, they can act as facultative stem cells for each 
other and replenish the inhibited cellular compartment by a process of 
transdifferentiation [14]. Liver cell proliferation occurs also at any time 
in normal liver, although very few hepatocytes proliferate and the 
mechanisms involved in this slow process in the absence of liver injury 
are not well understood [15]. Partial hepatectomy is one of the most 
studied animal experimental models of liver regeneration [16]. The 
complexity of the signaling pathways initiating and terminating this 
process has provided paradigms for regenerative medicine and any 
aspect of the mechanisms involved continues to be under active 
investigation. 
Very little is known about the role of NOXes during liver regenera-
tion. However, considering the function of NOX4 in inhibiting hepato-
cyte proliferation, we previously reported that Nox4 expression is down- 
regulated after partial hepatectomy in mice [10]. The aim of this work 
was to understand more about the role of Nox4 in this process taking 
advantage of experimental mouse models were Nox4 was deleted either 
in all cells or specifically in hepatocytes. The study is not only of interest 
because it provides an advanced understanding of the molecular 
mechanisms that regulate liver regeneration, but also to anticipate the 
potential of NOX4 inhibitors as therapeutic tools in human chronic liver 
pathologies. 
2. Material and methods 
2.1. Animal models 
NOX4− /− (B6.129-Nox4tm1Kkr/J) mice, generated in Dr. Krause’s 
Laboratory [17], were obtained from Jackson Laboratories (together 
with the corresponding C57BL/6J wild type (WT) mice) and housed at 
IDIBELL (Barcelona, Spain). Nox4 hepatocyte-specific knockout 
(NOX4hepKO) mice on a C57BL/6J background were generated in Dr. 
Török’s laboratory [18] and housed at University of California Davis 
(Sacramento, CA, USA). See Supplementary Fig. 1A for schematic 
description of the mouse models. 8 to 16-week-old male and female 
mice, hosted under 12 h light/dark cycle with free access to food and 
water were used in the study. All experiments complied with the EU 
Directive 2010/63/UE for animal experiments and the institution’s 
guidelines (Ethical Committee for animal experimentation of IDIBELL) 
and were approved by the General Direction of Environment and 
Biodiversity, Government of Catalonia (experiments in NOX4− /− mice, 
#4589) and the Animal Care Committee of UC Davis (experiments in 
NOX4hepKO mice). 
2.2. Experimental model of liver regeneration 
2/3 partial Hepatectomy (PH) was performed as described by Hig-
gins and Anderson [19]. Mice were euthanized at different times after 
surgery, as indicated in the figures. Tissue samples were immediately 
frozen in liquid nitrogen, cryopreserved in optimal cutting temperature 
compound (OCT) or fixed in 4% paraformaldehyde (PFA) and 
paraffin-embedded for further analysis. SHAM operated mice were used 
as control. Number of animals used in the study were minimized for 
ethical reasons. Thus, for NOX4− /− model between 3-10 animals were 
used per timepoint. For NOX4hepKO model between 2-3 animals per 
timepoint were analyzed and 2 different RNA extractions per animal 
liver tissue were done. 
2.3. Isolation of primary hepatocytes, cell culture and treatments 
Primary hepatocytes from NOX4hepKO, NOX4− /− and the corre-
sponding WT mice were isolated by collagenase (C5138, Sigma-Aldrich, 
St. Louis, MO) in situ perfusion as previously described [20], then 
cultured on collagen-coated plates using Williams’E medium (W4125, 
Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10–15% Fetal 
Bovine Serum (FBS), Penicillin (100 U/ml), Streptomycin (100 μg/mL) 
and maintained in a humidified atmosphere of 37 ◦C, 5% CO2. Between 
20-36 h after isolation, cells were serum-starved for 4–8 h before incu-
bation with fresh Williams’E medium supplemented with: FBS (2% or 
15%), human recombinant TGF-β1 (2 ng/mL) (616455, Calbiochem, La 
Jolla, CA, USA), Insulin (2 μM) (I9278, Sigma-Aldrich, St. Louis, MO, 
USA), Hydrocortisone (100 μM) (H2270, Sigma-Aldrich, St. Louis, MO, 
USA), EGF (20 ng/mL) (E9644, Sigma-Aldrich, St. Louis, MO, USA), as 
indicated in the figures. 
2.4. Western blot analysis 
Protein extracts and western blotting procedures were carried out as 
previously described [21]. Briefly, samples were lysed in RIPA lysis 
buffer supplemented with a protease inhibitors cocktail (1 mM PMSF, 
5 μg/mL Leupeptin, 0.1 mM Na3VO4, 0.5 mM DTT, 20 mM β-Glycer-
olphosphate) for 1 h at 4 ◦C. Protein was quantified with the Bio-Rad 
Protein Assay Dye Reagent Concentrate (Bio-Rad Laboratories, USA). 
Primary antibodies are summarized in Supplementary Table I. ECL 
Mouse IgG and Rabbit IgG, HRP-Linked antibodies (GE Healthcare, 
Buckinghamshire, UK) were used at 1:2000. Densitometric analysis was 
performed using ImageJ software (National Institutes of Health [NIH], 
Bethesda, MD, USA). 
2.5. Analysis of cell viability 
Viable cell numbers were determined by crystal violet staining. Cells 
were plated in 24-well plates. After treatments, culture medium was 
removed, cells were washed twice with PBS and then stained with 
crystal violet (0.2% w/v in 2% ethanol) for 30 min. Next, staining so-
lution was removed, and cells were washed with PBS to remove dye 
excess before being lysed in 10% Sodium Dodecyl Sulphate (SDS) for 
30 min. Absorbance was measured at 595 nm. Results were then calcu-
lated as the percentage of viable cells relative to time zero. 
2.6. Immunofluorescence staining 
For fluorescence microscopy studies, cells were plated on gelatin- 
coated glass coverslips. Primary hepatocytes were fixed with 4% PFA 
and permeabilized during 2 min with 0.1% Triton X-100. Cells were 
incubated with the primary antibody (Supplementary Table I) during 
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1 h, and then with a secondary anti-rabbit antibody coupled to Alexa 
Fluor 488 (Molecular Probes, Eugene, OR, USA) for 1 h. Nuclei were 
stained using DAPI (Sigma–Aldrich, Merck, Madrid, Spain). Cells were 
visualized in a Nikon eclipse 80i microscope and in a Leica TSC SL 
spectral confocal microscope. Representative images were taken and 
edited in Adobe Photoshop. ImageJ software (National Institutes of 
Health [NIH], Bethesda, MD, USA) was used to quantify positive nuclei. 
2.7. Immunohistochemistry and histology analysis 
Paraffin-embedded tissues were cut into 4-μm-thick sections. He-
matoxylin and Eosin (H&E) staining and immunohistochemistry (IHC) 
analysis were performed using standard procedures [21]. For IHC as-
says, sections were incubated overnight at 4 ◦C with the corresponding 
primary antibodies. Binding was developed with the Vectastain ABC KIT 
rabbit or mouse (PK-4001 and PK-4002, Vector Laboratories Inc., Bur-
lingame, CA, USA). Antibodies used and conditions are summarized in 
Supplementary Table I. Tissues were visualized in a Nikon Eclipse 80i 
microscope and representative images were taken with a Nikon DS-Ri1 
digital camera. ImageJ software (National Institutes of Health [NIH], 
Bethesda, MD, USA) was used to quantify all the parameters. 
2.8. Histological analysis of hepatic lipids 
Hepatic lipid drops were analyzed using Oil Red O staining. 10-μm- 
thick tissue sections in OCT were sequentially fixed with 4% PFA, 
washed with distilled water, rinsed with 60% isopropanol and washed 
with distilled water again. Then tissues were stained with freshly pre-
pared Oil Red O (O1391, Sigma Aldrich, St. Louis, MO, USA) working 
solution (3:2 v/v in distilled water) for 10 min at room temperature. 
After rinsing with 60% isopropanol and washing with distilled water for 
5 min, tissues were stained with Hematoxylin and mounted in Mowiol. 
Lipid droplets were visualized with a Nikon eclipse 80i microscope and 
representative images were taken with a Nikon DS-Ri1 digital camera. 
2.9. Analysis of gene expression 
E.Z.N.A.® Total RNA Kit II (Omega bio-tek, Norcross, GA, USA) was 
used following manufacturer’s protocol for total RNA isolation as pre-
viously described for tissues [21] and cells [22]. Reverse transcription 
(RT) was carried out with random primers using High Capacity RNA to 
cDNA Master Mix Kit (Applied Biosystems, Foster City, CA, USA). 1 μg of 
total RNA per sample was used. mRNA expression levels were deter-
mined in duplicates in a LightCycler® 480 Real Time PCR System, using 
the LightCycler® 480 SYBR Green I Master Mix (Roche Diagnostics 
GmbH, Mannheim, Germany). Gene expression was normalized to Rpl32 
mRNA content. See Supplementary Table II for primers sequences. 
2.10. RNA sequencing (RNA-seq) 
Total RNA from Mus musculus was quantified by Qubit® RNA BR 
Assay kit (Thermo Fisher Scientific) and the RNA integrity was esti-
mated by using RNA 6000 Nano Bioanalyzer 2100 Assay (Agilent). The 
RNA-seq libraries were prepared with KAPA Stranded mRNA-Seq Illu-
mina® Platforms Kit (Roche) following the manufacturer’s recommen-
dations. Briefly, 500 ng of total RNA was used for the poly-A fraction 
enrichment with oligo-dT magnetic beads, following the mRNA frag-
mentation. The strand specificity was achieved during the second strand 
synthesis performed in the presence of dUTP instead of dTTP. The blunt- 
ended double stranded cDNA was 3′adenylated and Illumina platform 
compatible adaptors with unique dual indexes and unique molecular 
identifiers (Integrated DNA Technologies) were ligated. The ligation 
product was enriched with 15 PCR cycles and the final library was 
validated on an Agilent 2100 Bioanalyzer with the DNA 7500 assay. The 
libraries were sequenced on HiSeq 4000 (Illumina) with a read length of 
2x51bp+17bp+8bp using HiSeq 4000 SBS kit (Illumina) and HiSeq 
4000 PE Cluster kit (Illumina), following the manufacturer’s protocol 
for dual indexing. Image analysis, base calling and quality scoring of the 
run were processed using the manufacturer’s software Real Time Anal-
ysis (RTA 2.7.7). 
Reads obtained by RNA-seq were mapped against Mus musculus 
reference genome (GRCm38) using STAR software version 2.5.3a [23] 
with ENCODE parameters for long reads. Annotated genes were quan-
tified using RSEM version 1.3.0 [24] with default parameters and the 
annotation file from GENCODE version M15. Differential expression 
analysis was performed withDESeq2 v1.26.0 R package [25], using a 
Wald test to compare the different time points between samples WT and 
NOX4− /− , and adjusting for sex. We considered differentially expressed 
genes (DEG) those with p-value adjusted <0.05 and absolute 
fold-change |FC|> 1.5. The heatmap was plotted with the ‘pheatmap’ R 
package using the shrunken log2 fold change of the DEG in each time 
point. Time course gene expression plots were generated using the 
normalized counts obtained with DESeq2 and the R package ‘ggplot2’. A 
Gene Ontology (GO) term enrichment analysis was performed with the 
differentially expressed genes using the R package gProfileR v0.7.0 [26], 
based on GO terms from the ENSEMBL database. Networks of 
protein-protein interactions were generated using the webtool 
STRINGdb (https://string-db.org/). 
2.11. Statistical analyses 
Data are represented as Mean ± Standard Error of the Mean (SEM). 
Differences between groups were compared using Student’s t-test with 
Welch correction (when comparing two groups) or Two-way ANOVA 
with Tukey’s multiple comparison post-hoc test (differences between 
groups considering two independent variables). Survival curves were 
estimated by Kaplan-Meier analysis, and significance was tested by the 
log-rank test. Statistical calculations were performed using GraphPad 
Prism software (GraphPad for Science Inc., San Diego, CA, USA). Dif-
ferences were considered statistically significant when p < 0.05. 
3. Results 
3.1. Nox4 deletion accelerated liver mass recovery and parenchymal 
structure 
NOX4− /− and NOX4hepKO mice (see Material & Methods section) 
were used to analyze the response to 2/3 PH. We previously reported 
that Nox4 expression decreases after PH in C57BL/6 mice [10]. Here we 
confirmed that decrease in Nox4 mRNA levels also occurred in 
NOX4floxp+/+ mice, the WT mice used for breeding and obtaining the 
NOX4hepKO mice (Supplementary Fig. 1B). We next analyzed how 
Nox4 deletion affects the liver expression of other members of the Nox 
gene family. Nox2 expression was not significantly different between 
WT and KO mice in any of the groups and its expression decreased, 
recovering later, in response to PH (no significant differences between 
WT and KO mice, Supplementary Fig. 1C). Expression of Nox1 was very 
low, barely detected by Real-Time PCR and with huge fluctuations 
among animals (Supplementary Fig. 1D). These results indicate that the 
absence of Nox4 expression is not compensated by differences in the 
expression of other members of the family. 
When the Liver/Body weight ratio was analyzed at different times 
after PH, we observed a significant earlier recovery in both NOX4− /−
and NOX4hepKO mice when compared to the corresponding WT mice 
(Fig. 1A and Supplementary Fig. 2A), which correlated with significant 
higher survival after PH in NOX4− /− mice (Fig. 1B). Although number 
of animals was lower to obtain statistical significance, a similar tendency 
was observed in NOX4hepKO mice (Supplementary Fig. 2B). Kinetics of 
the recovery after PH varied in both models of animals, probably due to 
the different background and different environment in the animal room 
(NOX4− /− mice were at IDIBELL in Barcelona; NOX4HepKO mice were 
at UC Davis, in CA). But it was clear that deletion of NOX4, either in the 
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whole animal or in the hepatocytes, induced an earlier recovery of the 
liver mass. H&E staining also revealed an earlier recovery of the 
parenchymal structure (Fig. 1C and Supplementary Fig. 2C). Liver 
steatosis, characteristic of the final G2/M phase of the hepatocyte cell 
cycle [12] was already resolved after 48 h in NOX4− /− mice, when 
maximal in WT yet (Fig. 1D). Furthermore, it was interesting to observe 
a transient higher size at 36 h after PH in hepatocytes from NOX4− /−
mice when compared to WT animals, which was also noticed in 
NOX4hepKO at 24 and 72 h after PH, when compared to NOX4floxp+/+
(Fig. 1E and Supplementary Fig. 2D). 
Altogether these results indicate that NOX4− /− and NOX4hepKO 
livers, after 2/3 PH, showed an earlier recovery of the liver parenchyma 
structure and regenerative steatosis, concomitant with a transient 
increase in hepatocyte size. Similar results were obtained in both 
NOX4− /− and NOX4HepKO mice and this would indicate that Nox4 
silencing has a higher impact on the hepatocyte responses to PH, which 
could be expected considering that the hepatocyte is the liver cell where, 
under normal physiological conditions, Nox4 expression is notably 
higher [6]. 
3.2. Accelerated and increased hepatocyte proliferation in NOX4hepKO 
mice after 2/3 PH 
In order to analyze whether the proliferative response of the hepa-
tocytes was altered in the absence of Nox4 expression, we performed 
IHC analysis of Ki67, as a marker of a proliferative cell cycle, and 
Fig. 1. Analysis of liver/body weight, mice survival and parenchymal structure in WT and NOX4¡/¡mice after 2/3 PH. (A) Mice were subjected to PH and 
sacrificed at the indicated times. Liver/Body weight ratio was calculated. Red bars represent the Median (n = 4–10 per time point). *p < 0.05 compared to previous 
time point. (B) Kaplan-Meier curve of overall survival in WT and NOX4− /− mice. (C) Representative images of Hematoxylin and Eosin (H&E) staining. (D) H&E 
(left) and Oil Red O staining (right). (E) β-catenin immunostaining performed (left) to quantify hepatocyte size (right). Red bars represent the Median. ***p < 0.001 
compared to WT. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
M. Herranz-Itúrbide et al.                                                                                                                                                                                                                     
Redox Biology 40 (2021) 101841
5
phospho-Histone3, as a more specific marker of G2/M phase, in the 
NOX4hepKO model. Results revealed a significant increase in the 
number of stained hepatocytes at 48 and 72 h after PH in NOX4hepKO 
when compared to NOX4floxp+/+ (Fig. 2A–B). Furthermore, NOX4-
hepKO hepatocytes reached the maximal DNA synthesis at 48 h after PH, 
whereas NOX4floxp+/+ reached it at 72 h. 
With the aim of better exploring the proliferative capacity of the 
hepatocytes, we isolated hepatocytes from unhepatectomized mice and 
cultured them to evaluate the response to FBS. Interestingly, very low 
concentrations of FBS (2%) allowed NOX4hepKO cells to increase 
almost 40% the number of viable cells in 24 h, significantly higher than 
the increase observed in NOX4floxp+/+ hepatocytes (Fig. 2C). This 
increase correlated with a much higher increase in the expression of 
Cyclin D1 (Ccnd1), Cyclin A2 (Ccnd2) and Cyclin B2 (Ccnb2) (Fig. 2D). 
Similar results were obtained in NOX4− /− isolated primary hepato-
cytes, correlating with increased Ki67 positive nuclei (Supplementary 
Figs. 3A–C). 
These results indicate that the absence of Nox4 expression primes 
hepatocytes for a faster and higher response to mitogenic signals. 
3.3. Accelerated regeneration correlated with an earlier induction of Myc 
expression 
We had previously described that Myc expression is required for an 
efficient liver regeneration in mice [27], as its deletion delays the re-
covery of the liver mass. Livers from NOX4− /− mice showed a higher 
increase in Myc expression 24 h after PH, and both 24 and 36 h after PH 
in NOX4HepKO livers (Fig. 3A) when compared to the corresponding 
WT mice. Western blot and IHC analysis revealed significantly higher 
c-Myc protein levels and c-Myc positive nuclei 36 h after PH in NOX4-
hepKO hepatocytes, which confirmed the differences observed at the 
mRNA level (Fig. 3B–C). Interestingly, primary cultures of hepatocytes 
from WT and NOX4− /− mice 30 h after PH, showed much higher in-
crease in Myc mRNA levels in NOX4− /− hepatocytes in response to FBS 
Fig. 2. Hepatocyte proliferation in NOX4floxpþ/þ and NOX4hepKO analyzed in livers after PH and in cultured hepatocytes. (A) Ki67 and (B) p-Histone 3 
immunostaining was performed in NOX4floxp+/+ and NOX4hepKO mice (left) and positive nuclei were quantified with ImageJ software (right). Red bars represent 
the Median. **p < 0.01, ***p < 0.001, ****p < 0.0001 compared to NOX4floxp+/+. (C–D) Primary hepatocytes isolated from NOX4floxp+/+ and NOX4hepKO 
mice were treated as indicated in the graph: C: Viable cell number represented as % of increase versus 0 time; D: RT-qPCR analysis of Ccnd1, Ccna2 and Ccnb2. 
Relative expression to Rpl32 gene. In C and D, Mean ± SEM (n = 3). *p < 0.05 compared to NOX4floxp+/+ (C). #p < 0.05, ###p < 0.001, ####p < 0.0001 
compared to untreated cells (D). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
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or a mitogenic mixture containing FBS, Insulin, Hydrocortisone and 
Epidermal Growth Factor (Supplementary Fig. 4A). These differences 
disappeared at 48 h after PH, where the response was even higher in the 
WT hepatocytes (Supplementary Fig. 4B). The increased Myc mRNA 
levels in response to mitogenic stimuli observed in NOX4− /− hepato-
cytes 30 h after PH correlated with relevant differences in c-Myc protein 
levels and higher increase in phospho-ERKs and phospho-Akt (Supple-
mentary Fig. 4C). 
All these results suggest that acceleration of liver regeneration in 
NOX4hepKO mice correlates with higher expression of Myc at mRNA 
and protein levels. 
3.4. RNA-seq analysis revealed significant transcriptomic changes in 
NOX4− /− versus WT mice after PH 
In order to better understand the molecular mechanisms that would 
Fig. 3. Analysis of c-Myc expression in livers after PH. (A) RT-qPCR analysis of Myc in livers from NOX4− /− and NOX4hepKO mice and their respective WT 
controls. Relative expression to Rpl32 gene. Red bars represent the Median (n = 4–10 per time point in NOX4− /− model; n = 4–6 per time point in NOX4hepKO 
model). *p < 0,05, **p < 0.01, ***p < 0.001, compared to WT controls. (B) Analysis of c-Myc by Western Blot in NOX4floxp+/+ and NOX4hepKO livers (left) and 
densitometry of the different experiments performed (right): Mean ± SEM (n = 3–4 per time point). β-actin was used as a loading control. (C) c-Myc immunostaining 
in NOX4floxp+/+ and NOX4hepKO livers after 36 h PH (left); positive nuclei quantified with ImageJ software (right). Red bars represent the Median. ** < p 0.01 
compared to NOX4floxp+/+. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
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justify the acceleration of liver regeneration and the differences in Myc 
expression found in NOX4 deleted mice, we performed RNA-seq analysis 
of liver samples from WT and NOX4− /− mice at 6 h, 24 h, 48 h and 
168 h after PH. Results revealed significant differences in gene expres-
sion between WT and NOX4− /− , particularly at 24 h after PH (Fig. 4A). 
The Gene Ontology (GO) enrichment analysis of the differentially 
expressed (DE) genes at 24 h showed that one of the significantly 
enriched pathways is “response to oxygen-containing compound”, of 
which one of the genes involved is Nox4. The network representation of 
the top100 DE genes (based on adjusted p-value) that belong to the 
aforementioned pathway (Supplementary Fig. 5) indicated a central role 
for Myc, whose expression appeared up-regulated at 6 h after PH in both 
WT and NOX4− /− livers, but at 24 h after PH was maintained at high 
levels only in NOX4− /− livers, whereas in WT livers decreased at basal 
levels (Fig. 4B). This differential expression pattern at 24 h was also 
observed in other relevant proliferation-related genes that appeared in 
the enriched oxygen-response network connected to Myc, such as Egr1, 
Sox9, Jund and Fosb, among others (Fig. 4B and Supplementary Fig. 5). 
Looking for mitogenic factors whose expression revealed changes, we 
only found a significant difference in the expression of a member of the 
Epidermal Growth Factor Receptor (EGFR) family, the Heparin Binding 
EGF-like Growth Factor (Hbegf gene), whose expression was signifi-
cantly higher at both 6 and 24 h after PH in NOX4− /− mice (Fig. 4C). No 
significant differences were observed in the expression of other members 
of the EGFR family or in the Met/Hgf (Hepatocyte Growth Factor) 
pathway. Interestingly, the top100 DE genes from the enriched oxygen- 
response network revealed an axis Nox4 – Src – Myc. In fact, Src 
expression significantly increased at 24 h after PH in NOX4− /− mice, 
whereas in WT mice no differences were observed (Fig. 4C). 
Among the potential processes that regulate hepatocyte prolifera-
tion, the TGF-β pathway is one of the most significant negative regula-
tors of the expression of Myc [28]. Coincident with the transcriptional 
changes observed at 24 h after PH in NOX4− /− mice, we observed 
differences in the expression of the Tgfb gene family. Tgfb1, the main 
isoform expressed in the liver, showed a significant decrease in its 
expression at 24 h, when compared to WT mice (Fig. 4D). In contrast, 
Tgfb2 showed increased expression, although in absolute terms, the level 
of expression is much lower than that of Tgfb1. Expression of Tgfb3 did 
Fig. 4. Transcriptomics RNA-seq analysis of livers after PH in WT and NOX4¡/¡ mice. (A) Heatmap showing all differentially expressed genes between 
NOX4− /− and WT mice in at least one time point (SHAM, 6 h, 24 h, 48 h and 168 h after PH). Changes in gene expression over time. *p < 0,05, **p < 0.01, ***p <
0.001, ****p < 0.00001. (B) Myc and other proliferation-related transcription factors; (C) Genes related to proliferation pathways; D) Genes related to the activation 
of the TGF-β pathway. 
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not show significant differences. Furthermore, we focused our attention 
into two genes that codify proteins whose function is related to the 
activation of the latent form of TGF-β1. Adamtsl2 (a disintegrin and 
metalloproteinase with thrombospondin repeats-like 2), which interacts 
with latent TGF-β binding protein 1 (LTBP1) and anchors it in the 
extracellular matrix [29], showed a differential pattern of expression 
almost significant (adjusted p-value = 0.068) in WT versus NOX4− /−
mice. Although its expression increased in WT at 6 h to decrease at 24 h, 
in NOX4− /− mice, the increase at 6 h was higher than in WT mice and 
its expression was maintained high at 24 h (Fig. 4D). Additionally, the 
expression of Bmp1, which cleaves LTBPs inducing TGF-β1 activation 
[30], was down-regulated at 6 h after PH in both WT and NOX4− /−
mice but, whereas in WT mice the levels returned to basal at 24 h, in 
NOX4− /− mice continued down-regulated even at lower levels at 24 h 
after PH (Fig. 4D). These results indicated that the TGF-β pathway could 
be differentially activated along the time in WT and NOX4− /− mice. 
Fig. 5. Analysis of the TGF-β pathway in WT and NOX4¡/¡ livers after PH. (A) TGF-β and (B) Smad3 immunostaining was performed in WT and NOX4− /−
mice. Arrows indicate Smad3 positive nuclei. Analysis of p-Smad3 (C), p21 (D) and caveolin-1 (E) by Western Blot (left). β-actin was used as a loading control. In (E), 
on right, caveolin-1 immunostaining. 
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3.5. After PH, Nox4− /− and NOX4hepKO livers showed an earlier and 
increased attenuation of the TGF-β pathway 
IHC analysis of the mature, active, form of TGF-β1 revealed that TGF- 
β1 staining considerably increased in WT liver tissues, but this increase 
was significantly lower in NOX4− /− and barely observed in NOX4-
HepKO at 24 and 36 h after PH, respectively (Fig. 5A and Supplementary 
Fig. 6A, respectively). This correlated with lower number of Smad3 
positive nuclei in NOX4− /− and NOX4HepKO, analyzed by IHC in liver 
tissues (Fig. 5B and Supplementary Fig. 6B). Western blot analysis 
revealed an increase in the levels of phospho-Smad3 after PH in both WT 
mice that was delayed and attenuated in NOX4− /− and NOX4HepKO 
mice (Fig. 5C and Supplementary Fig. 6C), correlating with decreased 
protein levels of one of its more relevant targets, p21, a cyclin-CDK 
inhibitor (Fig. 5D). Previous results had demonstrated that deficiency in 
the liver of caveolin-1, a protein that is located in lipid rafts at the cell 
membrane and involved in intracellular trafficking of receptors, impairs 
the TGF-β pathway and improves liver regeneration [31]. Interestingly, 
concomitant with the alteration in the activation of the TGF-β pathway, 
we found lower expression of caveolin-1 in NOX4− /− mice when 
compared to WT mice (Fig. 5E). 
Worthy to note that primary isolated hepatocytes from WT and 
NOX4− /− mice demonstrated a correct response to exogenous TGF-β1 
inhibiting FBS-induced increase in cyclins expression and hepatocyte 
proliferation, analyzed as cell number or Ki67+ cells, regardless Nox4 is 
expressed or not (Fig. 6A–C). Similar data were observed in primary 
hepatocytes from NOX4hepKO mice (results not shown). Levels of 
Smad2 phosphorylation in response to TGF-β1 were similar in WT and 
Fig. 6. Response of primary hepatocytes, isolated from WT and NOX4¡/¡ livers, to TGF-β. Primary hepatocytes isolated from WT and NOX4− /− mice were 
treated with 2% FBS with or without TGF-β1 for the time indicated in each graph. A representative experiment (n = 3) is shown. (A) RT-qPCR analysis of Ccnd1, 
Ccna2 and Ccnb2. Relative expression to Rpl32 gene. Bars represent the Mean from 2 independent plates. (B) Viable cell number represented as % versus 0 time. 
Mean ± SEM (6 independent plates). ** < p 0.01, ****p < 0.00001 compared to untreated cells. (C) % of Ki67 positive nuclei. Red bars represent the Median. *< p 
0.05 compared to WT cells. (D) Analysis of p-Smad2 and c-Myc by Western Blot. β-actin was used as a loading control. A representative experiment is shown. (E) c- 
Myc immunostaining was performed in WT and NOX4− /− mice to visualize the nuclear content. (For interpretation of the references to colour in this figure legend, 
the reader is referred to the Web version of this article.) 
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NOX4− /− hepatocytes (Fig. 6D). c-Myc levels were higher at basal 
levels, as well as in response to FBS, in NOX4− /− hepatocytes, but TGF- 
β1 showed identical capacity in inhibiting its up-regulation in WT and in 
NOX4− /− hepatocytes (Fig. 6D–E). These results suggest that Nox4 is 
not required for TGF-β1-induced growth inhibition of cell cycle. 
Altogether, in vivo results suggest that deletion of Nox4 in mice ac-
celerates liver regeneration, which correlates with changes in the tran-
scriptional program at 24 h after PH, increased expression of Myc and 
other mitogenic-related genes and attenuation in the activation of the 
TGF-β pathway (Fig. 7, left). In vitro results indicate that hepatocytes 
from Nox4 deleted mice show increased proliferative capacity, coinci-
dent with higher Myc and cyclins expression, in response to FBS or 
mitogenic signals, but they maintain the capacity to respond to TGF-β1 
in terms of growth inhibition (Fig. 7, right). 
4. Discussion 
Liver regeneration is a complex process that, despite extensive study, 
is not completely understood. Numerous signaling pathways, as well as 
interactions among different cell types, make the process extremely 
attractive to glean molecular insights into the self-renewal of mature 
cells, a property frequently associated with stem cells. Hepatocytes 
appear to be cell autonomous in deciding their replication fate, which 
depends on reprograming different molecular events in different cell 
types [32]. Results here support a role for Nox4 in negatively regulating 
liver regeneration. Interestingly, similar results were observed in 
NOX4− /− and NOX4HepKO models, which indicates that the effect on 
liver regeneration is mostly due to Nox4 function in hepatocytes. This is 
not surprising, since Nox4 expression is two orders of magnitude higher 
in hepatocytes than in other liver cell types, such as stellate cells, and 
even one order of magnitude higher than the expression in 
myofibroblasts, under fibrotic conditions [6]. In fact, residual Nox4 
expression in the livers of NOX4HepKO mice was barely detectable, 
lower than 0.5% when compared to the corresponding WT mice (results 
not shown). Nox4 expression is down-regulated after PH in mice, which 
is probably necessary for an efficient hepatocyte proliferation, due to its 
mitoinhibitory role [10]. Down-regulation of Nox4 might occur by the 
increase in proliferative signals, since both EGF and HGF inhibit its 
expression [33,34]. In the experimental animal models used in this 
study, where Nox4 expression is deleted, hepatocytes were more 
“primed” to respond to mitogenic signals in a fastest way. An interesting 
aspect to be mentioned is that although a slight increase in the liver to 
body weight ratio was observed in NOX4− /− mice versus WT, 
long-term analysis revealed that proliferation was arrested, and the liver 
reached a size that did not overcome the initial one. Many signals 
contribute to the termination of liver regeneration and maintenance of 
standard liver mass [15] and Nox4 does not appear to be essential for 
this process. 
Trying to analyze the potential mechanism that could be regulated 
by Nox4, we found a stronger activation of the c-Myc pathway in vivo, as 
well as in hepatocytes in culture. c-Myc is a relevant regulator of the 
expression of cell-cycle related genes [35] and it has been suggested that 
hepatocytes require up-regulation of Myc after PH to efficiently exit G0 
[27]. Interestingly, c-Myc not only regulates hepatocyte proliferation, 
but also cell size [27]. Here, the increase in Myc expression in Nox4 
deleted mice correlated with a significant increase in hepatocyte cell 
size. It is well known that hypertrophy without cell division precedes 
proliferation after 2/3 PH and almost equally contribute to regeneration 
[36]. The increase in cell size observed at 24–36 h after PH in both 
mouse models of Nox4 deletion correlated with the peak of Myc 
expression and preceded the peak of cell proliferation. Furthermore, 
c-Myc could also contribute to maintain lipid homeostasis, through 
Fig. 7. Summary diagram. Left: After partial hepatectomy, Nox4 deleted mice show earlier liver/body weight recovery, concomitant with higher proliferation, up- 
regulation of Myc and down-regulation of the TGF-β pathway. Right: Primary hepatocytes from Nox4 deleted mice show higher proliferation in response to FBS, 
while maintaining TGF-β-induced growth inhibitory response. 
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activating fatty acid oxidation for energy demands [37]. Indeed, over-
activation of c-Myc could also explain the faster recovery of regenerative 
liver steatosis observed in NOX4− /− mice. 
RNA-seq analysis revealed significant differences at the transcrip-
tional level after PH in NOX4− /− mice when compared to WT mice. The 
network of the top100 differentially expressed genes at 24 h from the 
“response to oxygen-containing compound” pathway located Myc in a 
node of proliferation-related genes whose expression decays at 24 h after 
PH in WT mice, but it is maintained, or even enhanced, at this same time 
in NOX4− /− mice. Significant increase in the expression of Hbegf, a 
member of the EGFR ligands family previously shown to have potent 
protective and mitogenic effects in liver regeneration [38], was 
observed specifically at 24 h after PH in NOX4− /− mice, as well as the 
expression of Src, a member of the cytosolic family of tyrosine kinase 
proteins. 
Different evidences support a role for TGF-β inhibiting Myc expres-
sion [28]. In hepatocytes, TGF-β1 inhibits growth and induces apoptosis 
in hepatocytes [39,40] and one of its earlier effects is down-regulation of 
the mitogen-induced Myc early expression [41], without an effect on the 
expression of other proto-oncogenes, such as Hras. Here, we found that 
acceleration of liver regeneration and increased expression of Myc in 
both mice models of Nox4 deletion could be attributed to the attenuation 
of the TGF-β pathway. It was proposed that transient escape of regen-
erative hepatocytes from TGF-β-induced growth inhibition and 
apoptosis is achieved through decrease in the expression of TGF-β re-
ceptors [42] and the acquisition of survival signals [43]. Nevertheless, a 
mitoinhibitory response to TGF-β is still present in regenerating hepa-
tocytes, since intravenous TGF-β1/2 reversibly inhibits the proliferative 
response of the liver to PH [44] and inactivation of the TGF-β pathway 
results in an increased proliferative response after PH [45]. Anti-TGF-β 
molecular intervention also facilitates liver regeneration upon acute 
dimethylnitrosamine (DMN) or CCl4 induced injury [46,47]. Results 
here indicate that in the absence of Nox4 expression, the TGF-β pathway 
was attenuated in hepatocytes, which could contribute to the accelera-
tion of the liver regeneration. 
Although it is well known that TGF-β up-regulates NOX4 in stellate 
cells and hepatocytes [6,7,9], it is less well recognized that NOX4 can 
reciprocally regulate TGF-β/SMAD signaling. The RNA-seq experiment 
revealed the potential mechanism responsible for this effect, which ap-
pears to be indirect, related to other cell-cell interactions and effects on 
extracellular matrix. On one side, TGF-β ligands, which are expressed in 
non-parenchymal liver cells, showed differences between WT and 
NOX4− /− mice. Tgfb1 expression was significantly lower at 24 h after 
PH in NOX4− /− mice when compared to WT mice. Another member of 
the family, Tgfb2, by contrast, showed higher levels but its expression 
was much lower than that of Tgfb1. TGF-β2 up-regulation correlates with 
fibrotic markers and play a prominent role in biliary liver diseases [48, 
49], but its expression during liver regeneration is 10 times lower than 
that of TGF-β1 [50]. Considering that Smad3 phosphorylation was 
clearly decreased in Nox4 deleted mice, the decrease in Tgfb1 expression 
appears to have a higher impact that the increase in Tgfb2 expression. 
Furthermore, activation of the latent TGF-β1 at the extracellular matrix 
may be affected by the absence of Nox4. In support of this hypothesis, 
Adamtsl2, which interacts with latent LTBP1 and anchors it to the 
extracellular matrix, showed an increase in its expression in NOX4− /−
mice at 24 h after PH. Mutations in ADAMTSL2 have been described in 
human diseases and lead to dysregulation of TGF-β signaling correlating 
with increase in active TGF-β1 [29]. Furthermore, the expression of 
Bmp1, a metalloproteinase that cleaves LTBPs releasing the active form 
of TGF-β1 [30], is decreased at 24 h after PH in NOX4− /− mice. Alto-
gether, these results reveal a mutual regulation between Nox4 and the 
TGF-β pathway: TGF-β1 is the main up-regulator of Nox4 expression and 
Nox4 could contribute to modulate the process of TGF-β1 activation. A 
fine down-regulation of Nox4 expression during the first hours after PH 
may be necessary for an efficient hepatocyte proliferation and liver 
regeneration. 
Despite these in vivo observations, in vitro experiments in NOX4− /−
hepatocytes indicated that they continue to respond to TGF-β1 in terms 
of growth inhibition, Smad2 phosphorylation or down-regulation of Myc 
levels, maintaining its suppressor function. Indeed, Nox4 deletion in-
creases the hepatocyte mitogenic response and modify the process of 
TGF-β1 activation in vivo, which increases the fastest and more efficient 
response of hepatocytes to mitogenic signals during liver regeneration. 
But the mechanism of response to extracellular TGF-β1 is not altered. 
NOX4 does not appear to be required for TGF-β1-mediated Myc down- 
regulation, which was proposed to be a SMAD-4 dependent mecha-
nism [51]. This could explain the arrest of proliferation in vivo long time 
after PH, when the expression/activation of TGF-β1, or other members 
of the family, increase. 
5. Conclusions 
NOX4 has been proposed as a potential therapeutic target in human 
liver chronic diseases [8], due to its role mediating TGF-β actions in liver 
fibrosis [5]. Results presented here would support the potential benefit 
of its inhibition also to favor liver regeneration from the remaining 
healthy hepatocytes. Nox4 does not appear to be essential for the 
termination of liver regeneration, which reinforces its potential as 
therapeutic target, without adverse effects. Nevertheless, considering 
that inhibiting NOX4 could be detrimental under preneoplastic condi-
tions, NOX4 inhibition must be considered at early stages of chronic 
inflammation and fibrosis in the liver. 
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